I stated the glass is always half full and you

I stated the glass is always half full and you twist that to glass is empty. Belittling posters expecting to make a profit on their investments should be beneath someone affiliated with the company. Your Price Is Right door #3 is the best scenario is nonsense, at least in 2019. Platinum Equity is not going to give Pharma Tech $100,000,000 or more licensing fee and then allow Pharma Tech to compete. They are not going to pay a $100,000,000 licensing fee anytime soon either, on a product that is not even approved yet. You are presumptuous assuming Platinum Equity's auditor will writedown on Lifescan? If Pharma Tech has a better test strip kudos for making a better mousetrap, but Pharma Tech has bragged in the past that they have a superior product and lower cost that Lifescan and barely got a toehold into the marketplace. For consumers, it appears trusting an established brand trumps a newcomer claiming to be a little more accurate.

Playing a Price is Right game of what is behind door #1, #2, and #3 is interesting, but at the end of the day, it is just more titillating bait to suck hope into investors. Suckers like me invest thousands of dollars and in return, the reward is promises and pennies. How many years does this "KB" need to make a profit, it has been at least 10 years now. Do you even speak for him and are your posts approved by management? Not that I care because I bet on a lawsuit, but a buyout works just as well.

Management or KB should stop being sensitive to criticisms and perform. ("By the way, you know KB is doing this without any capital") Who cares, it is his job. stop with the lame of excuses because at the end of the day it is just that, an excuse. It is the management job to fund the company. If the Company has all these great products funding should be easy. Platinum Equity just paid $2 billion dollars for a Company that you state is failing but KB cannot get funding for the Company. Before I start high fiving your let's take the Price is Right Door Number 3 game what are the details. Does Platinum Equity/Lifescan even want to work with Pharma Tech? Does Pharma Tech have a quality negotiating team? How do you know Platinum Equity hasn't already begun restructuring including and not limited to giving pink slips to senior and middle managers? And the biggest question regarding a licensing situation, would the $100 million or more be an upfront payment or amortized over years? If your Mr. KB arranges a $100,000,000 licensing agreement he would be congratulated not condemned.

I am not trashing yours or anyone else's opinions or analysis because you do enough of that for everyone. Door #3 is pie in the sky actually. Victory from the appeal and management would have better leverage for making what's behind door #3 deal assuming the mousetrap is an asset Lifescan values. It seems naive to take an Anon's word that Lifescan is interested in any outside assets.

You, and by extension management, would be better served by putting big boy pants on and stop whining and sniffling and concentrate on getting real results for shareholders. You are not part of the Me Too movement. Every company has a 24/7 kiss arse and apologist that never calls out management mistakes or their missed projections and opportunities. That makes reading your analysis 95% suspect. When posting opinions on SA the discourse tends to be more intelligent even when opinions differ. The share price is not going anywhere anytime soon absent a victory in the appeal. Increasing the value of the company will only happen if the appeal is won, otherwise, at the end of the day the hampster wheel will keep on spinning.